Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03686683
Title Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer (ProVent)
Acronym ProVent
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors Dendreon
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.